You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

List of Excipients in API tramadol hydrochloride


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing tramadol hydrochloride

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Trigen Laboratories LLC TRAMADOL HYDROCHLORIDE tramadol hydrochloride 13811-689 CELLULOSE, MICROCRYSTALLINE
Trigen Laboratories LLC TRAMADOL HYDROCHLORIDE tramadol hydrochloride 13811-689 ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER
Trigen Laboratories LLC TRAMADOL HYDROCHLORIDE tramadol hydrochloride 13811-689 FD&C BLUE NO. 2
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for tramadol hydrochloride

Excipient focus: 1-VINYL-2-PYRROLIDONE

Excipient focus: AMMONIA

Excipient focus: AMMONIUM LAURETH-5 SULFATE

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BUTYL ALCOHOL

Excipient focus: CARNAUBA WAX

Excipient focus: CELLULOSE ACETATE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CI 77492

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: DIBUTYL SEBACATE

Excipient focus: ETHYL ACRYLATE - METHYL METHACRYLATE COPOLYMER

Excipient focus: ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER

Excipient focus: ETHYLCELLULOSE

Excipient focus: ETHYLCELLULOSES

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE BLACK

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: GLYCERIN

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

Excipient focus: MODIFIED CORN STARCH

Excipient focus: POLYDEXTROSE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 1000

Excipient focus: POLYETHYLENE GLYCOL 3000

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 4000

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POVIDONE

Excipient focus: POVIDONE K25

Excipient focus: POVIDONE K29/32

Excipient focus: POVIDONE K30

Excipient focus: POVIDONE K90

Excipient focus: POVIDONES

Excipient focus: POWDERED CELLULOSE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICA

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BENZOATE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM PHOSPHATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: STARCH, CORN

Excipient focus: STARCH, PREGELATINIZED CORN

Excipient focus: STEARIC ACID

Excipient focus: SUCRALOSE

Excipient focus: SUCROSE STEARATE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: WATER

Excipient focus: XANTHAN GUM

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links